Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes
NCT00419484
·
clinicaltrials.gov ↗
COMPLETED
Status
1000
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes
Hypertension
Dyslipidemia
Diabetic Nephropathy
Interventions
DRUG:
pioglitazone
Sponsor
Dokkyo Medical University